This approval marks NeuroStar as the first and only transcranial magnetic stimulation (TMS) therapy cleared by the FDA for use in this younger demographic, expanding its indications to a fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback